Methicillin-resistant Staphylococcus aureus as a cause of community-acquired pneumonia

Current Infectious Disease Reports

Volumn 9, Issue 3, 2007, Pages 223-227

  Stankovic, Curt ^a   Mahajan, Prashant V ^b   Asmar, Basim I ^b  

^a CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CEFOTAXIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; CLOXACILLIN; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; GAMMA GLUTAMYLTRANSFERASE; GENTAMICIN; INOTROPIC AGENT; LEVOFLOXACIN; LINEZOLID; MACROLIDE; NAFCILLIN; OXACILLIN; PENICILLIN BINDING PROTEIN 2A; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; BACTERIAL ARTHRITIS; COMMUNITY ACQUIRED PNEUMONIA; CONTINUOUS INFUSION; DISEASE ASSOCIATION; DRUG BLOOD LEVEL; DRUG CHOICE; DRUG PENETRATION; EMPYEMA; HUMAN; INCIDENCE; INFLUENZA; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; OSTEOMYELITIS; PENICILLIN RESISTANCE; PLEURA EFFUSION; PNEUMONIA; REVIEW; SEPTIC SHOCK; SEPTICEMIA; SKIN INFECTION; SOFT TISSUE INFECTION;

EID: 34248593514     PISSN: 15233847     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11908-007-0035-y     Document Type: Review

References (30)

1. American Thoracic Society: Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. Am J Resp Crit Care Med 2001, 163:1730-1754.
2. Mokdad AH, Marks JS, Stroup DF, et al.: Actual causes of death in the United States, 2000. JAMA 2004, 291:1238-1245.
3. Mandell LA, Bartlett JG, Dowell SF, et al.: Infectious Diseases Society of America. Update of practice guidelines for the management of community-acquired pneumonia in immuno-competant adults. Clin Infect Dis 2003, 37:1405-1433.
4. Barrett FF, McGehee RF Jr, Finland M: Methicillin-resistant Staphylococcus aureus at Boston City Hospital: bacteriologic and epidemiologic observations. N Engl J Med 1968, 279:441-448.
5. Buckingham SC, King MD, Miller ML: Incidence and etiologies of complicated parapneumonic effusions in children, 1996 to 2001. Pediatr Infect Dis J 2003, 22:499-504.
6. Schultz KD, Fan LL, Pinsky J, et al.: The changing face of pleural empyemas in children: epidemiology and management. Pediatrics 2004, 113:1735-1740.
7. Buckingham SC, McDougal LK, Cathey LD, et al.: Emergence of community-acquired methicillin-resistant Staphylococcus aureus at a Memphis, Tennessee Children's Hospital. Pediatr Infect Dis J 2004, 23:619-624.
8. Katayama Y, Zhang H, Chambers HF: PBP 2a mutations producing very-high-level resistance to beta-lactams. Antimicrob Agents and Chemother 2004, 48:453-459.
9. Martinez-Aguilar R, Hammerman WA, Mason EO: Clindamycin treatment of invasive infections caused by community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus in children. Pediatr Infect Dis J 2003, 22:593-598.
10. Foster TJ: The Staphylococcus aureus "superbug." J Clin Invest 2004, 114:1693-1696.
11. Stankovic C, Mahajan PV: Healthy children with invasive community-acquired methicillin-resistant Staphylococcus aureus infections. Pediatr Emerg Care 2006, 22:361-363.
12. Mishaan AM, Mason EO Jr, Martinez-Aguilar G, et al.: Emergence of a predominant clone of community-acquired Staphylococcus aureus among children in Houston. Pediatr Infec Dis J 2005, 24:201-206.
13. Alfaro C, Fergie J, Purcell K: Emergence of community-acquired methicillin-resistant Staphylococcus aureus in complicated parapneumonic effusions. Pediatr Infect Dis J 2005, 24:274-276.
14. Honeybourne D, Tobin C, Jevons G, et al.: Intrapulmonary penetration of linezolid. Chest 2002, 122(4 Suppl):159s.
15. Konig B, Prevost G, Piemont Y, et al.: Effects of Staphylococcus aureus leukocidins on inflammatory mediator release from human granulocytes. J Infect Dis 1995, 171:607-613.
16. Lina G, Piemont Y, Godail-Gamot F, et al.: Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infection and pneumonia. Clin Infect Dis 1999, 29:1128-1132.
17. Gonzalez C, Rubio M, Romero-Vivas J, et al.: Bacteremic pneumonia due to Staphylococcus aureus: a comparison of disease caused by methicillin-resistant and methicillin-sensitive organisms. Clin Infect Dis 1999, 29:1171-1177.
18. The Centers for Disease Control and Prevention: Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus-Minnesota and North Dakota, 1997-1999. JAMA 1999, 282:1123-1125.
19. Gillet Y, Issartel B, Vanhems P, et al.: Association between Staphylococcus aureus trains carrying gene for Panton-Valentine leukocidin and highly lethal necrotizing pneumonia in young immunocompetent patients. Lancet 2002, 359:753-759.
20. Frazee BW, Salz TO, Perdreau-Remington F: Fatal community-associated methicillin-resistant Staphylococcus aureus pneumonia in an immunocompetent young adult. Ann Emerg Med 2005, 46:401-404.
21. Abramson JS, Lewis JC, Lyles DS, et al.: Inhibition of neutrophils lysosome-phagosome fusion associated with influenza virus infection in vitro. Role depressed bactericidal activity. J Clin Invest 1982, 69:1393-1397.
22. Hageman JC, Uyeki TM, Francis JS, et al.: Severe community-acquired pneumonia due to Staphylococcus aurcus, 2003-04 influenza season. Emerg Infect Dis 2006, 12:894-899.
23. Rello J, Diaz E, Bodi M: Appropriate treatment of pneumonia. Clin Infect Dis 2000, 31:1313-1315. [Comment on: Clin Infect Dis 1999, 29:1171-1177.]
24. Gonzalez C, Rubio M, Romero-Vivas J, Picazo JJ: Reply. Clin Infect Dis 2000, 31:1314-1315.
25. Cruciani M, Gatti G, Lazzarini L, et al.: Penetration of vancomycin into human lung tissue. J Antimicrob Chemother 1996, 38:865-869.
26. Conte JE Jr, Golden JA, Kipps J, et al.: Intrapulmonary pharmacokinetics of linezolid. Antimicrob Agents Chemother 2002, 46:1475-1480.
27. Como-Sabetti K, Glennen A, Barkus J, et al.: Inducible clindamycin resistance among erythromycin resistant community-onset methicillin resistant Staphylococcus aureus isolates in Minnesota, 2000-2001 [abstract 92]. Program and abstracts of the Infectious Disease Society of America 40th Annual Meeting. Chicago: Infectious Disease Society of America; 2002:61.
28. Frank AL, Marcinak JF, Mangat PD, et al.: Clindamycin treatment of methicillin-resistant Staphylococcus aureus infections in children. Pediatr Infect Dis J 2002, 21:530-534.
29. Meehan TP, Fine MJ, Krumholz HM, et al.: Quality of care, process and outcomes in elderly patients with pneumonia. JAMA 1997, 278:2080-2084.
30. Michelow IC, Olsen K, Lozano J, et al.: Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children. Pediatrics 2004, 113:701-707.